Key Takeaways
ICD-10 Code A64 is the billable code for unspecified sexually transmitted disease, valid for reimbursement since the 2016 code year and still billable in the current code year.
Use A64 only when laboratory workup is incomplete or inconclusive – a confirmed pathogen always warrants a more specific code within A50-A63.
Documentation must clearly explain why a more specific STD code could not be assigned; payers may scrutinize unspecified codes on audit.
Pabau’s claims management software helps sexual health and OBGYN practices structure ICD-10 coding workflows and reduce claim errors.
ICD-10 Code A64 is the billable ICD-10-CM code for unspecified sexually transmitted disease, used when an STD is suspected or probable but the specific pathogen cannot be confirmed.
It’s a legitimate, billable code that carries audit risk when used without proper clinical justification. STD-related claim denials often trace back to a code that’s too vague, paired with documentation that doesn’t explain why.
Practices serving patients with sexually transmitted infections need a clear framework for when A64 is appropriate and what the chart must say to support it.
This reference guide covers the clinical definition of A64, its correct usage criteria, how it fits within the A50-A64 ICD-10-CM block, documentation standards, and what billing teams need to know about reimbursement and payer sensitivity around unspecified STD codes.
Sexual health clinics and OBGYN practices will find the most direct application here, though primary care and urgent care settings also encounter this code regularly.
ICD-10 Code A64: Definition and clinical description
ICD-10 Code A64 carries the official descriptor “Unspecified sexually transmitted disease.” It is classified under ICD-10-CM Chapter 1 (Certain Infectious and Parasitic Diseases, A00-B99), within the subrange A50-A64: Infections with a predominantly sexual mode of transmission.
The code took effect with the ICD-10-CM transition on October 1, 2015, and has remained billable every code year since, including the current one.
The clinical definition covers any contagious disease acquired through sexual contact when the specific causative pathogen or infection type cannot be identified or confirmed at the time of coding.
Within the wider set of STD and STI ICD-10 codes, A64 sits at the bottom of the specificity ladder. It distinguishes itself from the more granular codes in the same block, which carry named conditions such as syphilis, gonorrhea, chlamydia, herpes, and anogenital warts.
Two synonyms appear in the ICD-10-CM index under A64: “sexually transmitted bacterial disease affecting skin” and “sexually transmitted disease NOS” (not otherwise specified). The NOS designation is important. It signals that A64 is a coding endpoint of last resort within this block, used only when no more precise code applies.
A50-A64 code hierarchy and where A64 fits
A64 is the final and least specific code in the A50-A64 block. Every other code in this range captures a named infection or a specific anatomical presentation. Understanding the full hierarchy is essential for correct assignment, because A64 is only appropriate after all other options in the block have been ruled out.
† A54 and A56 are category codes, not billable on their own – each needs an added character to bill (for example, A54.9 or A56.02). ‡ Within A57-A59, only A59 needs an added character (for example, A59.00); A57 and A58 are billable as shown.
The WHO’s ICD-10 classification maintains this hierarchy internationally, while the Centers for Medicare and Medicaid Services (CMS) and the National Center for Health Statistics (NCHS) maintain the U.S.-specific ICD-10-CM edition. Coders using the CDC/NCHS ICD-10-CM lookup tool will find A64 listed as a billable and specific code with no further subdivisions available below it.
When to use ICD-10 Code A64: Correct usage criteria
A64 is appropriate in a narrow set of clinical circumstances. The common thread is diagnostic uncertainty that is documented and clinically justified, not simply incomplete charting.
- Pending laboratory results: The encounter occurs before STI panel results return. The clinician documents a clinical suspicion of an STD with testing ordered. A64 may be assigned for the encounter; once results confirm a specific pathogen, the confirmed code should be used for subsequent encounters.
- Inconclusive or negative testing: Laboratory results return negative or indeterminate, but clinical presentation strongly suggests an STD. The chart documents the clinical rationale for maintaining the STD diagnosis despite negative tests.
- Empirical treatment: The provider initiates empirical antibiotic or antiviral therapy based on clinical presentation and exposure history before confirmation. A64 supports the encounter when a specific diagnosis cannot yet be established.
- Surveillance and screening encounters: Some payers and public health programs accept A64 for high-risk screening visits where STD exposure is documented but no specific diagnosis is confirmed. Verify payer policy before applying.
What A64 does not cover: confirmed diagnoses. Once laboratory results identify a specific pathogen – Neisseria gonorrhoeae, Chlamydia trachomatis, Treponema pallidum, or any other named organism – the appropriate specific code from A50-A63 must be used.
That means the ICD-10 code for chlamydia (A55-A56), gonorrhea (A54), syphilis (A50-A53), or trichomoniasis (A59), whichever the documentation supports. Assigning A64 when a more specific code is available is a coding error that creates audit exposure and may trigger claim denial.
For practices using claims management software, building a rule that flags A64 assignments for documentation review before submission reduces this risk significantly. Practices offering OBGYN services encounter this decision point frequently, particularly with chlamydia and gonorrhea co-testing scenarios.

Pro Tip
Before defaulting to A64, run a quick code exclusion check: syphilis (A50-A53), gonorrhea (A54), chlamydia (A55-A56), herpes (A60), warts (A63.0). If any of these can be supported by clinical findings or lab results, that specific code applies. A64 is only correct when no specific code in A50-A63 can be supported.
Documentation requirements for ICD-10 Code A64
Unspecified codes carry higher documentation scrutiny than specific codes. Payers and auditors treat A64 as a signal that either the diagnostic workup is incomplete or the coder selected the wrong code. Sound documentation neutralizes both interpretations.
The chart note supporting an A64 assignment should include four elements.
- Clinical basis for STD suspicion: Symptoms, exposure history, or patient-reported risk factors that justify initiating an STD evaluation. This does not need to be exhaustive, but it must be present.
- Tests ordered and timing: Document which STI tests were ordered and when results are expected. If results were pending at the time of the encounter, note this explicitly.
- Why a specific code was not assigned: A brief statement such as “STI panel pending; specific organism not yet identified” or “clinical presentation consistent with STD, laboratory results indeterminate” gives auditors the context they need.
- Treatment plan: Empirical treatment decisions and their rationale. This reinforces that the A64 assignment reflects active clinical judgment, not documentation shortfall.
Privacy considerations matter here too. STD diagnoses are subject to heightened confidentiality protections under many state laws and under HIPAA. HIPAA compliance guidance includes ensuring that ICD-10-coded diagnoses in billing records are handled with appropriate access controls, especially for sensitive conditions like sexually transmitted infections.
Practices that use digital intake forms and structured clinical documentation tools can build STI-specific templates that capture all four elements automatically, reducing the risk that a chart note will fail documentation review.
Structured patient record systems also make it easier to update the diagnosis code when laboratory results return, replacing A64 with the confirmed specific code in follow-up encounters. The same discipline applies to any code that changes as a care plan evolves, whether that’s an updated diagnosis or a durable equipment code like HCPCS E0261.

Manage STI coding workflows without the guesswork
Pabau helps sexual health, OBGYN, and primary care practices structure clinical documentation, flag unspecified codes for review, and submit cleaner claims – all from one platform.
Related and adjacent ICD-10 codes to consider before assigning A64
Choosing A64 should follow a deliberate exclusion process. Several codes outside the A50-A64 block also apply to sexually transmitted conditions and may be more accurate in specific clinical contexts.
HIV is worth emphasizing specifically. ICD-10 Code B20 governs HIV disease and is entirely separate from the A50-A64 block. Coders who encounter a patient with HIV and concurrent unspecified STD exposure should code both separately: B20 for the HIV diagnosis and A64 (or a more specific A50-A63 code) for the STD component, per ICD-10-CM sequencing rules.
Coders often confuse A64 with Z11.3 in asymptomatic screening contexts. A patient presenting for a routine annual STI panel with no symptoms and no confirmed exposure does not warrant A64.
Z11.3, the ICD-10 code for STI screening, is the correct code for that encounter. A64 requires at minimum a clinical basis for suspecting an active or recent sexually transmitted infection.
A64 vs Z20.2: Coding sexually transmitted disease exposure
A different code applies when the encounter is about exposure rather than a suspected active infection. The ICD-10 code for sexually transmitted disease exposure is Z20.2 – contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission. Reach for Z20.2, not A64, when a patient reports contact but shows no symptoms.
This STI exposure ICD-10 scenario is the one coders most often miscode as A64. When a patient was exposed to a partner’s diagnosed infection but has no signs of disease, Z20.2 captures the STD exposure accurately. A64 only fits once clinical findings point to an active infection that testing has not yet named.
Coders can cross-reference the full A50-A64 code set using the AAPC Codify ICD-10-CM lookup to verify current code descriptions, inclusion notes, and exclusion markers before finalizing any A64 assignment. Reviewing the situational anxiety ICD-10 code guide for another commonly unspecified condition also helps coders understand where the “use most specific code” principle applies across chapters.
Pro Tip
A64 and Z20.2 are frequently confused. Z20.2 is for patients with documented exposure but no active disease or symptoms. A64 applies when clinical signs suggest an active STD is present but cannot yet be confirmed. When in doubt, check whether the patient has symptoms: symptoms point toward A64, documented exposure without symptoms points toward Z20.2.
Billing, reimbursement, and audit considerations for A64
A64 is billable for reimbursement purposes across commercial payers, Medicaid, and Medicare when documentation supports the unspecified designation. However, unspecified codes attract additional scrutiny in payer audits and medical necessity reviews.
Payer behavior varies. Some Medicaid plans and commercial insurers use claims data analytics to flag high rates of A64 usage at the provider level. A practice that routinely submits A64 without ever following up with more specific codes may generate a pattern that triggers a medical record request or prepayment review.
This pattern isn’t unique to A64. Unspecified and narrowly defined codes carry similar audit exposure elsewhere, from neurological sequelae coding under G09 to anesthesia billing under CPT 00794. The sensitive nature of STD diagnoses simply raises the stakes for A64 specifically.
A peer-reviewed validation study published in PubMed Central (PMC7855200) examined how A64 performs in surveillance research for chlamydia and gonorrhea case identification.
Researchers defined true positive A64 cases as those accompanied by any positive STI laboratory test. That reinforces the clinical expectation that A64 shouldn’t appear in a chart without at least some laboratory engagement, even if results are pending.
Three practical steps reduce billing risk when A64 is used regularly in a practice’s case mix.
- Close the loop on pending results: Build a workflow that flags A64-coded encounters for follow-up when lab results return. If results confirm a specific pathogen, the diagnosis should be updated before the next related claim is submitted.
- Track A64 frequency internally: Practices that see a high proportion of A64 among STD-related encounters should investigate whether clinical documentation and coding practices are aligned. The goal is not to avoid A64 but to use it only when clinically justified.
- Use compliance workflows proactively: Compliance management tools that include coding review checkpoints help prevent A64 from becoming a default choice for coders under time pressure.
Patient privacy adds another billing dimension. STD diagnoses on Explanation of Benefits (EOB) documents are subject to state-level confidentiality rules that vary significantly.
Practices billing through insurance for STD-related services should review their patient data security practices to ensure that coded diagnoses aren’t inadvertently disclosed through standard billing communications. Some states require that STD-related EOBs be suppressed entirely from household mailings.
For practices managing a mixed caseload of STD-related encounters, structured HIPAA compliance software with coding oversight and documentation audit trails is worth implementing before volume grows. Retroactive compliance remediation is significantly more costly than building documentation habits from the start.
Conclusion
ICD-10 Code A64 is a legitimate, billable code with a narrow clinical justification: use it when an STD is suspected or probable but a specific pathogen cannot yet be confirmed. The documentation must explain why – pending labs, inconclusive results, or empirical treatment – or the code becomes a liability rather than a clinical record.
Pabau’s claims management software helps sexual health, OBGYN, and primary care practices build the coding review checkpoints and documentation workflows that keep A64 usage accurate and audit-ready. To see how it fits your practice’s workflow, book a demo.
Continue your research
Running a sexual health practice and need software built for it? Sexual health clinic software covers intake, documentation, and compliant billing workflows in one platform.
Want to see how Pabau handles clinical documentation under HIPAA? HIPAA compliance guidance outlines the key requirements for protecting sensitive patient records.
Looking for a reference on another frequently unspecified ICD-10 condition? Situational anxiety ICD-10 code covers correct usage, documentation requirements, and related code selection.
Need to understand OBGYN-specific EMR workflows? OBGYN EMR software supports the documentation and coding demands of reproductive and sexual health practice.
Frequently asked questions
ICD-10 Code A64 is the billable ICD-10-CM diagnosis code for unspecified sexually transmitted disease. It is classified under Chapter 1 (Certain Infectious and Parasitic Diseases) within the A50-A64 block (Infections with a predominantly sexual mode of transmission). Coders use it when an STD is clinically suspected or probable but a specific causative organism cannot be confirmed at the time of the encounter.
Use A64 when laboratory results are pending, inconclusive, or unavailable, and clinical judgment supports an STD diagnosis. If a specific pathogen has been identified – such as Chlamydia trachomatis or Neisseria gonorrhoeae – use the corresponding specific code from A50-A63 instead. A64 is never appropriate when a more precise diagnosis can be supported by the available clinical evidence.
Yes, A64 is a billable and specific ICD-10-CM code, valid for reimbursement purposes since the 2016 code year and still billable in the current code year. It has no further subdivisions, which means it functions as a terminal coding endpoint for unspecified STD diagnoses. Payers will reimburse claims coded with A64 when documentation justifies the unspecified designation.
The primary ICD-10-CM range for infections with a predominantly sexual mode of transmission is A50-A64. This block includes syphilis (A50-A53), gonorrhea (A54), chlamydial infections (A55-A56), herpes (A60), anogenital warts (A63.0), other specified STDs (A63.8), and unspecified STD (A64). HIV disease is coded separately under B20, not within this block.
The A50-A64 block covers congenital and acquired syphilis, gonococcal infections, chlamydial lymphogranuloma and other chlamydial STDs, anogenital herpesviral infections, anogenital warts, and other predominantly sexually transmitted conditions. Chlamydia (A56) and gonorrhea (A54) are the most frequently coded conditions in the block in U.S. clinical practice, with A64 used as the residual category when a specific pathogen cannot be confirmed.
Use Z20.2 for STI exposure, not A64. Z20.2 covers contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission, and it applies when a patient reports exposure but has no symptoms and no confirmed infection. A64 becomes appropriate only when clinical findings suggest an active sexually transmitted disease that testing has not yet identified.
It depends on the clinical picture. With documented symptoms or clinical suspicion of an active infection but no confirmed pathogen, A64 (unspecified sexually transmitted disease) applies while testing is pending. With no symptoms and only worry or a reported exposure, a screening code such as Z11.3 or an exposure code such as Z20.2 fits better than A64.